Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal.
Lemler
M S
MS
Department of Pediatric Cardiology, University of Colorado, USA.
Schaffer
M S
MS
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D004077:Digoxin / Q000008:administration & dosage*; D004562:Electrocardiography / Q000379:methods; D004947:Esophagus; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D011237:Predictive Value of Tests; D011433:Propranolol / Q000008:administration & dosage*; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D013617:Tachycardia, Supraventricular / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D004077:Digoxin; D011433:Propranolol